Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 53

1.

The preoperative level of physical activity is associated to the postoperative recovery after elective cholecystectomy - A cohort study.

Onerup A, Angerås U, Bock D, Börjesson M, Fagevik Olsén M, Gellerstedt M, Haglind E, Nilsson H, Angenete E.

Int J Surg. 2015 May 21;19:35-41. doi: 10.1016/j.ijsu.2015.05.023. [Epub ahead of print]

PMID:
26003290
2.

Stoma-Const--the technical aspects of stoma construction: study protocol for a randomised controlled trial.

Correa Marinez A, Erestam S, Haglind E, Ekelund J, Angerås U, Rosenberg J, Helgstrand F, Angenete E.

Trials. 2014 Jun 27;15:254. doi: 10.1186/1745-6215-15-254.

3.

Patient-reported genitourinary dysfunction after laparoscopic and open rectal cancer surgery in a randomized trial (COLOR II).

Andersson J, Abis G, Gellerstedt M, Angenete E, Angerås U, Cuesta MA, Jess P, Rosenberg J, Bonjer HJ, Haglind E.

Br J Surg. 2014 Sep;101(10):1272-9. doi: 10.1002/bjs.9550. Epub 2014 Jun 12.

4.

Health-related quality of life after laparoscopic and open surgery for rectal cancer in a randomized trial.

Andersson J, Angenete E, Gellerstedt M, Angerås U, Jess P, Rosenberg J, Fürst A, Bonjer J, Haglind E.

Br J Surg. 2013 Jun;100(7):941-9. doi: 10.1002/bjs.9144.

5.

Sacral nerve stimulation (SNS), posterior tibial nerve stimulation (PTNS) or acupuncture for the treatment for fecal incontinence: a clinical commentary.

Hultén L, Angerås U, Scaglia M, Delbro D.

Tech Coloproctol. 2013 Oct;17(5):589-92. doi: 10.1007/s10151-013-0985-z. Epub 2013 Mar 22. Review.

PMID:
23519985
6.

Extended use of dabigatran, warfarin, or placebo in venous thromboembolism.

Schulman S, Kearon C, Kakkar AK, Schellong S, Eriksson H, Baanstra D, Kvamme AM, Friedman J, Mismetti P, Goldhaber SZ; RE-MEDY Trial Investigators; RE-SONATE Trial Investigators.

N Engl J Med. 2013 Feb 21;368(8):709-18. doi: 10.1056/NEJMoa1113697.

7.

[From chaos to order with programs against obesity].

Angerås U, Brohall G, Fagerberg B, Björkelund C, Lantz H, Lönroth H, Stenlöf K.

Lakartidningen. 2011 Dec 7-13;108(49):2594-7. Swedish. No abstract available.

PMID:
22468398
8.

Current controversies in colorectal surgery: the way to resolve uncertainty and move forward.

Rosenberg J, Fischer A, Haglind E; Scandinavian Surgical Outcomes Research Group.

Colorectal Dis. 2012 Mar;14(3):266-9. doi: 10.1111/j.1463-1318.2011.02896.x.

PMID:
22122825
9.

Mortality after groin hernia surgery: delay of treatment and cause of death.

Nilsson H, Nilsson E, Angerås U, Nordin P.

Hernia. 2011 Jun;15(3):301-7. doi: 10.1007/s10029-011-0782-4. Epub 2011 Jan 26.

PMID:
21267615
10.

Effect of body mass index on groin hernia surgery.

Rosemar A, Angerås U, Rosengren A, Nordin P.

Ann Surg. 2010 Aug;252(2):397-401. doi: 10.1097/SLA.0b013e3181e985a1.

PMID:
20647921
11.

[Chaos waiting without a national program for obesity surgery].

Fagerberg B, Angerås U.

Lakartidningen. 2010 Jan 13-19;107(1-2):8-9. Swedish. No abstract available.

PMID:
20184265
12.

Prevention of venous thromboembolism with an oral factor Xa inhibitor, YM150, after total hip arthroplasty. A dose finding study (ONYX-2).

Eriksson BI, Turpie AG, Lassen MR, Prins MH, Agnelli G, Kälebo P, Wetherill G, Wilpshaar JW, Meems L; ONYX-2 STUDY GROUP.

J Thromb Haemost. 2010 Apr;8(4):714-21. doi: 10.1111/j.1538-7836.2010.03748.x. Epub 2010 Jan 17.

PMID:
20088935
13.

Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients.

Schulman S, Angerås U, Bergqvist D, Eriksson B, Lassen MR, Fisher W; Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis.

J Thromb Haemost. 2010 Jan;8(1):202-4. doi: 10.1111/j.1538-7836.2009.03678.x. Epub 2009 Oct 30. Review.

PMID:
19878532
14.

Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial.

Turpie AG, Lassen MR, Davidson BL, Bauer KA, Gent M, Kwong LM, Cushner FD, Lotke PA, Berkowitz SD, Bandel TJ, Benson A, Misselwitz F, Fisher WD; RECORD4 Investigators.

Lancet. 2009 May 16;373(9676):1673-80. doi: 10.1016/S0140-6736(09)60734-0. Epub 2009 May 4.

PMID:
19411100
15.

Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial.

Kakkar AK, Brenner B, Dahl OE, Eriksson BI, Mouret P, Muntz J, Soglian AG, Pap AF, Misselwitz F, Haas S; RECORD2 Investigators.

Lancet. 2008 Jul 5;372(9632):31-9. doi: 10.1016/S0140-6736(08)60880-6. Epub 2008 Jun 24.

PMID:
18582928
16.

Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty.

Lassen MR, Ageno W, Borris LC, Lieberman JR, Rosencher N, Bandel TJ, Misselwitz F, Turpie AG; RECORD3 Investigators.

N Engl J Med. 2008 Jun 26;358(26):2776-86. doi: 10.1056/NEJMoa076016.

17.

Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty.

Eriksson BI, Borris LC, Friedman RJ, Haas S, Huisman MV, Kakkar AK, Bandel TJ, Beckmann H, Muehlhofer E, Misselwitz F, Geerts W; RECORD1 Study Group.

N Engl J Med. 2008 Jun 26;358(26):2765-75. doi: 10.1056/NEJMoa0800374.

18.

Body mass index and groin hernia: a 34-year follow-up study in Swedish men.

Rosemar A, Angerås U, Rosengren A.

Ann Surg. 2008 Jun;247(6):1064-8. doi: 10.1097/SLA.0b013e31816b4399.

PMID:
18520236
19.

Safety assessment of new antithrombotic agents: lessons from the EXTEND study on ximelagatran.

Agnelli G, Eriksson BI, Cohen AT, Bergqvist D, Dahl OE, Lassen MR, Mouret P, Rosencher N, Andersson M, Bylock A, Jensen E, Boberg B; EXTEND Study Group.

Thromb Res. 2009;123(3):488-97. doi: 10.1016/j.thromres.2008.02.017. Epub 2008 May 15.

PMID:
18485453
20.

Body mass index and diverticular disease: a 28-year follow-up study in men.

Rosemar A, Angerås U, Rosengren A.

Dis Colon Rectum. 2008 Apr;51(4):450-5. Epub 2007 Dec 22.

PMID:
18157570
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk